India's government is reported to be planning the launch of a public-private partnership for stores which would sell cheap generic drugs for poorer segments of the population. In principle, medicines sold at these outlets would cost half the rate of branded equivalents, the Economic Times of India stated.
A pilot project covering 15 of India's 35 states and union territories is planned for the first phase, with the government providing about 300,000 rupees ($6,870) for each outlet, including land and construction. The locations will be chosen for their proximity to public hospitals and clinics.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze